Member overview

Experimentelle Pharmakologie & Onkologie Berlin-Buch GmbH

Key figures

  • Founded: 1997
  • Employees: 45
  • expert service in preclinical research & development of new cancer drugs
  • models for each preclinical development phase:
    • Target identification and validation
    • Lead optimization
    • Translational research
  • Major R&D-Topics:
    • Biomarker research for targeted tumor therapy
    • Stem cell research

Products & Technologies

Our services and experiences cover the following fields of preclinical research:

  • Determination of in vitro and in vivo antitumor activity of investigational compounds
  • Identification & validation of targets and biomarkers
  • Pharmacokinetic and biodistribution studies
  • Toxicology and pathology
  • Genetic profiling with RT-PCR, Affymetrix, Illumina, Sequencing (NGS)
  • Humanized mouse models for immune oncology
  • Tumor imaging and radiation studies

We offer

  • Contract research solutions in Experimental Pharmacology & Oncology Research
  • Consulting & Support for commercialization of new models or projects (
  • Evaluation of individualized treatment options for cancer patients


Please contact us for further information: